Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Ting Chun Hung; Alagie Jassey; Ching Hsuan Liu; Chien Ju Lin; Chun Ching Lin; Shu Hui Wong; Jonathan Y. Wang; Ming Hong Yen; Liang Tzung Lin

doi:10.1016/j.phymed.2022.154128

Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Ting Chun Hung, Alagie Jassey, Ching Hsuan Liu, Chien Ju Lin, Chun Ching Lin, Shu Hui Wong, Jonathan Y. Wang, Ming Hong Yen, Liang Tzung Lin

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

Original language	English
Article number	154128
Journal	Phytomedicine
Volume	102
DOIs	https://doi.org/10.1016/j.phymed.2022.154128
Publication status	Published - Jul 20 2022

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Complementary and alternative medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.phymed.2022.154128

Cite this

Hung, T. C., Jassey, A., Liu, C. H., Lin, C. J., Lin, C. C., Wong, S. H., Wang, J. Y., Yen, M. H., & Lin, L. T. (2022). Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025)). Phytomedicine, 102, Article 154128. https://doi.org/10.1016/j.phymed.2022.154128

@article{70ffd3d315974542a908139bbd49b303,

title = "Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))",

abstract = "In P.67, Section BBR interacts with HCV envelope glycoprotein E2: {"}E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol{"} should read {"}E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol{"}; and {"}the highest binding energy of 6.7 kcal/mol{"} should read {"}the lowest binding energy of −6.7 kcal/mol{"}.",

author = "Hung, {Ting Chun} and Alagie Jassey and Liu, {Ching Hsuan} and Lin, {Chien Ju} and Lin, {Chun Ching} and Wong, {Shu Hui} and Wang, {Jonathan Y.} and Yen, {Ming Hong} and Lin, {Liang Tzung}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier GmbH",

year = "2022",

month = jul,

day = "20",

doi = "10.1016/j.phymed.2022.154128",

language = "English",

volume = "102",

journal = "Phytomedicine",

issn = "0944-7113",

publisher = "Urban und Fischer Verlag Jena",

}

TY - JOUR

T1 - Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

AU - Hung, Ting Chun

AU - Jassey, Alagie

AU - Liu, Ching Hsuan

AU - Lin, Chien Ju

AU - Lin, Chun Ching

AU - Wong, Shu Hui

AU - Wang, Jonathan Y.

AU - Yen, Ming Hong

AU - Lin, Liang Tzung

PY - 2022/7/20

Y1 - 2022/7/20

N2 - In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

AB - In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

UR - http://www.scopus.com/inward/record.url?scp=85129742214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129742214&partnerID=8YFLogxK

U2 - 10.1016/j.phymed.2022.154128

DO - 10.1016/j.phymed.2022.154128

M3 - Comment/debate

C2 - 35550221

AN - SCOPUS:85129742214

SN - 0944-7113

VL - 102

JO - Phytomedicine

JF - Phytomedicine

M1 - 154128

ER -

Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this